Skip to main content
. 2017 Mar-Apr;33(2):471–475. doi: 10.12669/pjms.332.11937

Table-I.

Clinical profile of Study population

Parameter No of patients/ Eyes
Symptoms (n=18)*
Headache 15 (83.33%)
Transient Visual obscuration 8 (44.44%)
Nausea/Vomiting 4 (22.22%)
Diplopia 3 (16.67%)
Etiology (n=18)
IIH 11 (61.11%)
Dural Sinus Thrombosis 4 (22.22%)
Intracranial Mass 3 (16.67%)
BCVA (n=31)
6/60 1 (3.20%)
5/60 5 (16.10%)
4/60 5 (16.10%)
3/60 6 (19.50%)
2/60 9 (29.00%)
1/60 5 (16.10%)
Frisen Stage (n=31)
5 3 (9.70%)
4 15 (48.40%)
3 13 (41.90%)
*

Occurrence of multiple symptoms in few patients account for percentage distribution of >100%